Abstract

Multiple sclerosis is the most common disabling neurological disease of young adults. The ability to impact the quality of life of patients with multiple sclerosis should not only incorporate therapies that are disease modifying, but should also include a course of action for the global multidisciplinary management focused on quality of life and functional capabilities.

Original languageEnglish (US)
Pages (from-to)83-98
Number of pages16
JournalTherapeutic Advances in Neurological Disorders
Volume4
Issue number2
DOIs
StatePublished - Mar 2011

Fingerprint

Multiple Sclerosis
Quality of Life
Young Adult
Therapeutics

Keywords

  • fatigue
  • multiple sclerosis
  • neurogenic bowel and bladder
  • spasticity
  • symptomatic therapy
  • visual symptoms

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Pharmacology

Cite this

Symptomatic therapy in multiple sclerosis. / Frohman, Teresa C.; Castro, Wanda; Shah, Anjali; Ortstadt, Jeffrey L; Ortstadt, Jeffrey; Davis, Scott L.; Logan, Diana; Abraham, Thomas; Abraham, Jaspreet; Remington, Gina; Treadaway, Katherine; Greenberg, Benjamin; Shah, Anjali; Hart, John; Stuve, Olaf; Lemack, Gary E; Frohman, Elliot.

In: Therapeutic Advances in Neurological Disorders, Vol. 4, No. 2, 03.2011, p. 83-98.

Research output: Contribution to journalArticle

Frohman, TC, Castro, W, Shah, A, Ortstadt, JL, Ortstadt, J, Davis, SL, Logan, D, Abraham, T, Abraham, J, Remington, G, Treadaway, K, Greenberg, B, Shah, A, Hart, J, Stuve, O, Lemack, GE & Frohman, E 2011, 'Symptomatic therapy in multiple sclerosis', Therapeutic Advances in Neurological Disorders, vol. 4, no. 2, pp. 83-98. https://doi.org/10.1177/1756285611400658
Frohman, Teresa C. ; Castro, Wanda ; Shah, Anjali ; Ortstadt, Jeffrey L ; Ortstadt, Jeffrey ; Davis, Scott L. ; Logan, Diana ; Abraham, Thomas ; Abraham, Jaspreet ; Remington, Gina ; Treadaway, Katherine ; Greenberg, Benjamin ; Shah, Anjali ; Hart, John ; Stuve, Olaf ; Lemack, Gary E ; Frohman, Elliot. / Symptomatic therapy in multiple sclerosis. In: Therapeutic Advances in Neurological Disorders. 2011 ; Vol. 4, No. 2. pp. 83-98.
@article{354dcb7ca37945c9b767342dc70720cd,
title = "Symptomatic therapy in multiple sclerosis",
abstract = "Multiple sclerosis is the most common disabling neurological disease of young adults. The ability to impact the quality of life of patients with multiple sclerosis should not only incorporate therapies that are disease modifying, but should also include a course of action for the global multidisciplinary management focused on quality of life and functional capabilities.",
keywords = "fatigue, multiple sclerosis, neurogenic bowel and bladder, spasticity, symptomatic therapy, visual symptoms",
author = "Frohman, {Teresa C.} and Wanda Castro and Anjali Shah and Ortstadt, {Jeffrey L} and Jeffrey Ortstadt and Davis, {Scott L.} and Diana Logan and Thomas Abraham and Jaspreet Abraham and Gina Remington and Katherine Treadaway and Benjamin Greenberg and Anjali Shah and John Hart and Olaf Stuve and Lemack, {Gary E} and Elliot Frohman",
year = "2011",
month = "3",
doi = "10.1177/1756285611400658",
language = "English (US)",
volume = "4",
pages = "83--98",
journal = "Therapeutic Advances in Neurological Disorders",
issn = "1756-2856",
publisher = "SAGE Publications Ltd",
number = "2",

}

TY - JOUR

T1 - Symptomatic therapy in multiple sclerosis

AU - Frohman, Teresa C.

AU - Castro, Wanda

AU - Shah, Anjali

AU - Ortstadt, Jeffrey L

AU - Ortstadt, Jeffrey

AU - Davis, Scott L.

AU - Logan, Diana

AU - Abraham, Thomas

AU - Abraham, Jaspreet

AU - Remington, Gina

AU - Treadaway, Katherine

AU - Greenberg, Benjamin

AU - Shah, Anjali

AU - Hart, John

AU - Stuve, Olaf

AU - Lemack, Gary E

AU - Frohman, Elliot

PY - 2011/3

Y1 - 2011/3

N2 - Multiple sclerosis is the most common disabling neurological disease of young adults. The ability to impact the quality of life of patients with multiple sclerosis should not only incorporate therapies that are disease modifying, but should also include a course of action for the global multidisciplinary management focused on quality of life and functional capabilities.

AB - Multiple sclerosis is the most common disabling neurological disease of young adults. The ability to impact the quality of life of patients with multiple sclerosis should not only incorporate therapies that are disease modifying, but should also include a course of action for the global multidisciplinary management focused on quality of life and functional capabilities.

KW - fatigue

KW - multiple sclerosis

KW - neurogenic bowel and bladder

KW - spasticity

KW - symptomatic therapy

KW - visual symptoms

UR - http://www.scopus.com/inward/record.url?scp=79955990115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955990115&partnerID=8YFLogxK

U2 - 10.1177/1756285611400658

DO - 10.1177/1756285611400658

M3 - Article

C2 - 21694806

AN - SCOPUS:79955990115

VL - 4

SP - 83

EP - 98

JO - Therapeutic Advances in Neurological Disorders

JF - Therapeutic Advances in Neurological Disorders

SN - 1756-2856

IS - 2

ER -